8-Chloro-3,4-dihydro-2,7-naphthyridin-1(2H)-one

Catalog No.: 
ACTOZW478
CAS No.: 
1289188-58-4
Molecular Formula: 
C8H7ClN2O
Molecular Weight: 
182.61
8-Chloro-3,4-dihydro-2,7-naphthyridin-1(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$501.00In stockInquiry
250mg98%$800.00In stockInquiry
500mg98%$1333.00In stockInquiry
1g98%$1999.00InquiryInquiry
5g98%$5995.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Chloro-3,4-dihydro-2,7-naphthyridin-1(2H)-one
IUPAC Name8-chloro-3,4-dihydro-2,7-naphthyridin-1(2H)-one
MDL No.MFCD16974311
Molecular FormulaC8H7ClN2O
Molecular Weight182.61
SMILESO=C1NCCC2=CC=NC(Cl)=C12
InChI KeyPSUCOROPFZXCLP-UHFFFAOYSA-N
Synonym8-chloro-3,4-dihydro-2,7-naphthyridin-1(2H)-one;2,7-Naphthyridin-1(2H)-one, 8-chloro-3,4-dihydro-;8-chloro-3,4-dihydro-2H-2,7-naphthyridin-1-one
CAS No.1289188-58-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTOZW478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOZW478 route product structure diagram
    ACTOZW4781289188-58-4In Stock
Inquiry

2. ACTOZW478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOZW478 route product structure diagram
    ACTOZW4781289188-58-4In Stock
Inquiry

3. ACTOZW478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOZW478 route product structure diagram
    ACTOZW4781289188-58-4In Stock
Inquiry

Comments (0)